Applied DNA Sciences (NASDAQ:APDN) Rating Increased to Buy at Zacks Investment Research
Applied DNA Sciences (NASDAQ:APDN – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Thursday, Zacks.com reports. The firm presently has a $1.50 price target on the technology company’s stock. Zacks Investment Research‘s price target suggests a potential upside of 9.49% from […]